Eli Lilly and Company (LLY) vs Palantir Technologies Inc. (PLTR)

Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.

Palantir Technologies is an artificial intelligence, data analytics, and automated decision-making company that helps organizations improve efficiency through data-driven operations. It serves commercial customers through its Foundry platform and government clients through Gotham. Palantir works exclusively with organizations in Western-allied nations and maintains the right to decline engagements it views as contrary to Western values. Founded in 2003, the company became publicly traded in 2020.